ANEB
Price
$2.40
Change
-$0.04 (-1.64%)
Updated
Sep 26 closing price
Capitalization
98.6M
Earnings call today
PALI
Price
$0.90
Change
+$0.13 (+16.88%)
Updated
Sep 26 closing price
Capitalization
8.37M
Interact to see
Advertisement

ANEB vs PALI

Header iconANEB vs PALI Comparison
Open Charts ANEB vs PALIBanner chart's image
Anebulo Pharmaceuticals
Price$2.40
Change-$0.04 (-1.64%)
Volume$36.76K
Capitalization98.6M
Palisade Bio
Price$0.90
Change+$0.13 (+16.88%)
Volume$1.24M
Capitalization8.37M
ANEB vs PALI Comparison Chart in %
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. PALI commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and PALI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ANEB: $2.40 vs. PALI: $0.90)
Brand notoriety: ANEB and PALI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 6% vs. PALI: 39%
Market capitalization -- ANEB: $98.6M vs. PALI: $8.37M
ANEB [@Biotechnology] is valued at $98.6M. PALI’s [@Biotechnology] market capitalization is $8.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whilePALI’s FA Score has 1 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • PALI’s FA Score: 1 green, 4 red.
According to our system of comparison, PALI is a better buy in the long-term than ANEB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 5 TA indicator(s) are bullish while PALI’s TA Score has 4 bullish TA indicator(s).

  • ANEB’s TA Score: 5 bullish, 4 bearish.
  • PALI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ANEB is a better buy in the short-term than PALI.

Price Growth

ANEB (@Biotechnology) experienced а -4.76% price change this week, while PALI (@Biotechnology) price change was +49.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ANEB is expected to report earnings on Sep 29, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANEB($98.6M) has a higher market cap than PALI($8.37M). ANEB YTD gains are higher at: 42.857 vs. PALI (-45.564). ANEB has higher annual earnings (EBITDA): -7.27M vs. PALI (-11.83M). ANEB has more cash in the bank: 13.3M vs. PALI (5.42M). ANEB (0) and PALI (0) have equivalent revenues.
ANEBPALIANEB / PALI
Capitalization98.6M8.37M1,178%
EBITDA-7.27M-11.83M61%
Gain YTD42.857-45.564-94%
P/E RatioN/A0.02-
Revenue00-
Total Cash13.3M5.42M246%
Total DebtN/A338K-
FUNDAMENTALS RATINGS
PALI: Fundamental Ratings
PALI
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBPALI
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FEBO0.720.04
+6.54%
Fenbo Holdings Limited
INCY82.701.04
+1.27%
Incyte Corp
ARMP3.010.03
+1.01%
Armata Pharmaceuticals
ABL5.870.05
+0.86%
Abacus Global Management Inc
WBTN19.44-0.61
-3.04%
Webtoon Entertainment Inc.

ANEB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-1.64%
ABVX - ANEB
47%
Loosely correlated
+1.02%
ABCZF - ANEB
31%
Poorly correlated
N/A
AVXL - ANEB
31%
Poorly correlated
+1.88%
CLSD - ANEB
30%
Poorly correlated
+8.31%
PALI - ANEB
28%
Poorly correlated
+16.20%
More

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
+16.20%
CDTX - PALI
82%
Closely correlated
+6.77%
TAOX - PALI
81%
Closely correlated
+6.95%
NCNA - PALI
81%
Closely correlated
+0.75%
NBY - PALI
80%
Closely correlated
+2.34%
AGEN - PALI
80%
Closely correlated
+1.28%
More